Thermo Fisher Scientific Inc.
TMO· NYSE
Filed Jul 31, 2009 · 10-Q · 34 days after period end · 0000097745-09-000040
| Metric | Q2 2009 | Q2 2008 |
|---|---|---|
| Revenue | $2.48B | $2.71B |
| Net Income | $206.90M | $246.10M |
| EPS Diluted | $0.49 | $0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
ended Jun 27, 2009 · filed Jul 31, 2009 · 34 d after period end